Hans-Guido Wendel

8PUBLICATIONS
63CO-AUTHORS
Haematological tumoursEvolution of developmental systemsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 19, 2023
Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma.

Ana Portelinha, Mariana da Silva Ferreira, Tatiana Erazo

|Aug 24, 2022
A Rapid Translational Immune Response Program in CD8 Memory T Lymphocytes.

Darin Salloum, Kamini Singh, Natalie R Davidson

|Sep 15, 2021
Ectopic activation of the miR-200c-EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy.

Minggang Zhang, Zeguo Zhao, Yuri Pritykin

|Mar 29, 2019
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells.

Eric L Smith, Kim Harrington, Mette Staehr

|Jun 30, 2017
Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma.

Elisa Oricchio, Natalya Katanayeva, Maria Christine Donaldson

Pageof 2